Trupanion Partners with HABRI to Strengthen Human-Animal Bond
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 10 2026
0mins
Should l Buy TRUP?
Trupanion announced a new partnership with the Human Animal Bond Research Institute, or HABRI, to advance shared efforts that support and strengthen the human-animal bond. HABRI and Trupanion will work jointly to recognize the essential role pets and service animals play in people's lives. Research demonstrates that service dogs are a valuable complementary treatment for veterans with PTSD, helping to reduce symptom severity and improve quality of life.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy TRUP?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on TRUP
Wall Street analysts forecast TRUP stock price to rise
6 Analyst Rating
4 Buy
2 Hold
0 Sell
Moderate Buy
Current: 26.040
Low
42.00
Averages
54.40
High
63.00
Current: 26.040
Low
42.00
Averages
54.40
High
63.00
About TRUP
Trupanion, Inc. is a medical insurance provider for cats and dogs throughout the United States, Canada, certain countries in Continental Europe, and Australia. The Company operates in two segments, namely, Subscription Business and Other Business. The Subscription Business segment includes subscription fees related to the Company's direct-to-consumer products. The Other Business segment comprises other product offerings that generally have a business-to-business relationship and a different margin profile than its subscription segment, including writing policies on behalf of third parties and other products and software solutions. It offers Trupanion, software that is designed to communicate directly with veterinary hospital's practice management software. It provides Powered by Trupanion pet insurance product offerings marketed by third parties and marketed under the brand names Furkin and PHI Direct in Canada, and a Trupanion branded product in Germany and Switzerland.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Employers Recognize Employee Pet Care Needs
- Emerging Employee Trend: As U.S. companies mandate a full return to office, pet care is increasingly recognized as a vital short-term support service, with approximately 59 million Americans providing family care in 2024, highlighting the strong demand for pet care.
- Significant Absenteeism Impact: A survey by Wagmo reveals that 75% of pet owners missed work due to pet care issues in the past year, with 26% missing six or more days, indicating a direct impact on employee productivity.
- Expanded Corporate Benefits: Wellthy introduced pet care into its back-up services in 2024, with around 50% of clients offering this benefit, showcasing innovation and adaptability in employee welfare aimed at enhancing satisfaction and retention rates.
- Context of Caregiving Crisis: While pet care may not be the most urgent need, Wellthy's service expansion aligns with the founder's personal caregiving experiences, aiming to alleviate financial and emotional stress for families, thereby improving overall workplace productivity.
See More
Trupanion CFO Sells Final Shares Under Diversification Plan
- Sale Overview: Trupanion CFO Fawwad Qureshi sold 2,837 shares of common stock on February 27, 2026, for approximately $75,000, reflecting his decision to implement a financial diversification plan.
- Execution of Trading Plan: This transaction marks the seventh consistent sale since May 2025, all executed under the same plan, indicating Qureshi's methodical unwinding of his position rather than reacting to market conditions.
- Impact on Ownership: Following the transaction, Qureshi holds zero shares directly or indirectly in Trupanion, indicating a complete exit from the company's equity with no outstanding derivatives or options.
- Market Reaction and Strategy: While Qureshi's sale may raise eyebrows, the lack of discretion over timing and pricing, coupled with the stated reason for diversification, suggests that investors should view this as standard financial planning rather than a negative signal.
See More
Trupanion CFO Completes Final Stock Sale
- Stock Sale Overview: On February 27, 2026, Trupanion CFO Fawwad Qureshi sold 2,837 shares at a weighted average price of $26.46, totaling approximately $75,000, marking the complete liquidation of his direct holdings.
- Ownership Changes: This transaction reduced Qureshi's direct and indirect ownership to zero, reflecting a consistent pattern of declining holdings over the past year, with the sale executed entirely through direct ownership and no indirect holdings or derivative securities reported.
- Trading Plan Context: The stock sale was conducted under a 10b5-1 trading plan established in May 2025 aimed at financial diversification, indicating that the sale is not a negative signal regarding the company's outlook but rather a standard financial strategy.
- Market Reaction and Investor Advice: While Qureshi's sale may raise eyebrows, analysts note that CFOs diversifying out of concentrated stock positions is a common financial practice, and investors should monitor future trading activities before considering purchasing Trupanion stock.
See More
Trupanion Stock Drops 33.7%: Investment Risks and Opportunities
- Significant Stock Decline: Trupanion's stock has plummeted 33.7% over the past six months, now trading at $28.77, raising concerns among investors about its future performance and prompting a reevaluation of their investment strategies.
- Weak Asset Expansion: The company's book value per share (BVPS) has only grown by 10.4% over the last two years, indicating limited capacity for asset expansion, which could negatively impact its long-term financial health and market competitiveness.
- Poor Return on Equity: Trupanion has averaged a negative return on equity (ROE) of -7.5% over the past five years, a disappointing figure that not only reflects poor performance in absolute terms but also highlights a lack of competitive advantage compared to other insurers achieving over 20% ROE, potentially undermining investor confidence in its future profitability.
- Cautious Investment Advice: While Trupanion is not a terrible business, its current market performance and financial metrics fall short of investor expectations, leading analysts to recommend that investors consider other more promising opportunities, especially in a rapidly changing market environment.
See More
Trupanion Management to Attend Investor Conferences
- Investor Conference Schedule: Trupanion's management will participate in the 2026 BofA Securities Animal Health Summit, with Margi Tooth and Fawwad Qureshi presenting at 12:25 PM ET on February 26, enhancing investor engagement and trust throughout the day.
- Annual Conference Highlights: At the 47th Annual Raymond James Institutional Investor Conference on March 2, Margi Tooth will present at 9:15 AM ET, showcasing the company's leadership in pet medical insurance, which is expected to boost brand awareness and market influence.
- Technological Advantage Showcase: Trupanion's patented technology allows for direct payments to veterinarians within seconds at checkout, ensuring pet owners experience peace of mind regarding medical expenses, which not only enhances customer satisfaction but may also attract more pet owners to its insurance services.
- Market Coverage Overview: With over 1 million pets insured across the U.S., Canada, and parts of Europe, Trupanion continues to provide high-value medical insurance, further solidifying its leadership position in the pet insurance market.
See More
Trupanion Reports Record Q4 2025 Earnings and Strategic Outlook
- Record Performance: Trupanion achieved total revenue of $376.9 million in Q4 2025, marking a 12% year-over-year increase, with nearly $1 billion in subscription revenue for the year, highlighting the company's strong growth potential in the pet insurance market.
- Significant Net Pet Growth: The company reported a 50% net pet growth in Q4 and a 10% increase for the full year, driven by aggressive investments in new pet acquisition, reflecting management's confidence in future market opportunities.
- Improved Profitability: Adjusted operating income reached $45 million in Q4, up 26% year-over-year, while the subscription adjusted operating margin increased to 16.5%, demonstrating effective strategies in cost control and revenue growth.
- Optimistic 2026 Outlook: Management projects total revenue for 2026 to range between $1.55 billion and $1.582 billion, with subscription revenue expected to grow by 14%, indicating a continued focus on market expansion and new product development to seize growth opportunities.
See More
Employers Recognize Employee Pet Care Needs
- Emerging Employee Trend: As U.S. companies mandate a full return to office, pet care is increasingly recognized as a vital short-term support service, with approximately 59 million Americans providing family care in 2024, highlighting the strong demand for pet care.
- Significant Absenteeism Impact: A survey by Wagmo reveals that 75% of pet owners missed work due to pet care issues in the past year, with 26% missing six or more days, indicating a direct impact on employee productivity.
- Expanded Corporate Benefits: Wellthy introduced pet care into its back-up services in 2024, with around 50% of clients offering this benefit, showcasing innovation and adaptability in employee welfare aimed at enhancing satisfaction and retention rates.
- Context of Caregiving Crisis: While pet care may not be the most urgent need, Wellthy's service expansion aligns with the founder's personal caregiving experiences, aiming to alleviate financial and emotional stress for families, thereby improving overall workplace productivity.
See More
Trupanion CFO Sells Final Shares Under Diversification Plan
- Sale Overview: Trupanion CFO Fawwad Qureshi sold 2,837 shares of common stock on February 27, 2026, for approximately $75,000, reflecting his decision to implement a financial diversification plan.
- Execution of Trading Plan: This transaction marks the seventh consistent sale since May 2025, all executed under the same plan, indicating Qureshi's methodical unwinding of his position rather than reacting to market conditions.
- Impact on Ownership: Following the transaction, Qureshi holds zero shares directly or indirectly in Trupanion, indicating a complete exit from the company's equity with no outstanding derivatives or options.
- Market Reaction and Strategy: While Qureshi's sale may raise eyebrows, the lack of discretion over timing and pricing, coupled with the stated reason for diversification, suggests that investors should view this as standard financial planning rather than a negative signal.
See More
Trupanion CFO Completes Final Stock Sale
- Stock Sale Overview: On February 27, 2026, Trupanion CFO Fawwad Qureshi sold 2,837 shares at a weighted average price of $26.46, totaling approximately $75,000, marking the complete liquidation of his direct holdings.
- Ownership Changes: This transaction reduced Qureshi's direct and indirect ownership to zero, reflecting a consistent pattern of declining holdings over the past year, with the sale executed entirely through direct ownership and no indirect holdings or derivative securities reported.
- Trading Plan Context: The stock sale was conducted under a 10b5-1 trading plan established in May 2025 aimed at financial diversification, indicating that the sale is not a negative signal regarding the company's outlook but rather a standard financial strategy.
- Market Reaction and Investor Advice: While Qureshi's sale may raise eyebrows, analysts note that CFOs diversifying out of concentrated stock positions is a common financial practice, and investors should monitor future trading activities before considering purchasing Trupanion stock.
See More
Trupanion Stock Drops 33.7%: Investment Risks and Opportunities
- Significant Stock Decline: Trupanion's stock has plummeted 33.7% over the past six months, now trading at $28.77, raising concerns among investors about its future performance and prompting a reevaluation of their investment strategies.
- Weak Asset Expansion: The company's book value per share (BVPS) has only grown by 10.4% over the last two years, indicating limited capacity for asset expansion, which could negatively impact its long-term financial health and market competitiveness.
- Poor Return on Equity: Trupanion has averaged a negative return on equity (ROE) of -7.5% over the past five years, a disappointing figure that not only reflects poor performance in absolute terms but also highlights a lack of competitive advantage compared to other insurers achieving over 20% ROE, potentially undermining investor confidence in its future profitability.
- Cautious Investment Advice: While Trupanion is not a terrible business, its current market performance and financial metrics fall short of investor expectations, leading analysts to recommend that investors consider other more promising opportunities, especially in a rapidly changing market environment.
See More
Trupanion Management to Attend Investor Conferences
- Investor Conference Schedule: Trupanion's management will participate in the 2026 BofA Securities Animal Health Summit, with Margi Tooth and Fawwad Qureshi presenting at 12:25 PM ET on February 26, enhancing investor engagement and trust throughout the day.
- Annual Conference Highlights: At the 47th Annual Raymond James Institutional Investor Conference on March 2, Margi Tooth will present at 9:15 AM ET, showcasing the company's leadership in pet medical insurance, which is expected to boost brand awareness and market influence.
- Technological Advantage Showcase: Trupanion's patented technology allows for direct payments to veterinarians within seconds at checkout, ensuring pet owners experience peace of mind regarding medical expenses, which not only enhances customer satisfaction but may also attract more pet owners to its insurance services.
- Market Coverage Overview: With over 1 million pets insured across the U.S., Canada, and parts of Europe, Trupanion continues to provide high-value medical insurance, further solidifying its leadership position in the pet insurance market.
See More
Trupanion Reports Record Q4 2025 Earnings and Strategic Outlook
- Record Performance: Trupanion achieved total revenue of $376.9 million in Q4 2025, marking a 12% year-over-year increase, with nearly $1 billion in subscription revenue for the year, highlighting the company's strong growth potential in the pet insurance market.
- Significant Net Pet Growth: The company reported a 50% net pet growth in Q4 and a 10% increase for the full year, driven by aggressive investments in new pet acquisition, reflecting management's confidence in future market opportunities.
- Improved Profitability: Adjusted operating income reached $45 million in Q4, up 26% year-over-year, while the subscription adjusted operating margin increased to 16.5%, demonstrating effective strategies in cost control and revenue growth.
- Optimistic 2026 Outlook: Management projects total revenue for 2026 to range between $1.55 billion and $1.582 billion, with subscription revenue expected to grow by 14%, indicating a continued focus on market expansion and new product development to seize growth opportunities.
See More
